Flow imaging microscopy analysis provides users qualitative analysis of biological and non-biological particles in various industries. It helps in particle characterization, counting and measurement in concentration using digital imaging techniques without reagents or staining. The technique uses hydrodynamic focusing to arrange particles in a viewing plane for better imaging and analysis. Pharmaceutical and biotechnology companies majorly use this technique to ensure quality, safety and efficacy of their drugs, vaccines and biotherapeutics. It is used in analyzing active pharmaceutical ingredients, final drug products, raw materials, formulations and more. The applications ranges from quality control, process optimization to research and development activities.

The global Flow Imaging Microscopy Analysis Market is estimated to be valued at Us$ 145 Million in 2023 and is expected to exhibit a CAGR Of 8.7% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Increasing regulatory compliances in the pharmaceutical industry has been a key trend driving the flow imaging microscopy analysis market growth. Pharmaceutical companies are required to meet various regulatory standards set by agencies like FDA, EMA and others with respect to drug development and manufacturing. Flow imaging microscopy techniques helps companies to streamline their quality control operations in compliance with regulations. Similarly, rising adoption of biosimilars has also supported market growth. Biosimilars require intensive characterization of biological molecules and particles, in which flow imaging microscopy analysis plays a vital role. Moreover, technological advancements like development of high throughput automated systems, software integration and cloud-based image analysis services are further extending applications of this technique across industries. However, high costs of instruments and need for trained professionals remain key challenges for wider market adoption.

Porter’s Analysis

Threat of new entrants: The flow imaging microscopy analysis market requires high capital investment and emerging technologies which acts as a barrier for new entrants.

Bargaining power of buyers: Buyers have high bargaining power due to availability of substitutes.

Bargaining power of suppliers: Suppliers have moderate bargaining power owing to availability of alternative components.

Threat of new substitutes: Substitutes like impedance-based cell counters provide strong competition.

Competitive rivalry: The market players focus on product portfolio expansion and strategic collaborations to strengthen their position in the flow imaging microscopy analysis market.

Key Takeaways

The Global Flow Imaging Microscopy Analysis Market Demand is expected to witness high growth.

North America currently dominates the market owing to developed healthcare infrastructure and availability of skilled professionals. Asia Pacific is expected to witness fastest growth on account of rising healthcare spending and increasing penetration of flow cytometry techniques in disease diagnosis and research applications.

Key players operating in the flow imaging microscopy analysis market are Bio-Rad Laboratories, Sysmex, Merck, Agilent Technologies, Siemens Healthcare, Danaher, PerkinElmer, and Miltenyi Biotec. These players focus on achieving inorganic growth initiatives such as acquisitions, partnerships, and expansions to strengthen their market position. For instance, in 2018, Bio-Rad Laboratories acquired the cytometry business of Advanced Analytical Technologies to enhance its existing flow cytometry portfolio.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it